Abstract
Lexigen (formerly Fuji ImmunoPharmaceuticals) is developing FP- 21399.
| Original language | English |
|---|---|
| Pages (from-to) | 1293-1295 |
| Number of pages | 3 |
| Journal | IDrugs |
| Volume | 4 |
| Issue number | 11 |
| Publication status | Published - 2001 |
ASJC Scopus subject areas
- Pharmacology